by IR Team | Dec 9, 2021 | Press Releases
Northern Response International To Distribute Seratopical Revolution® Masstige LineLOS ANGELES and TORONTO, Dec. 09, 2021 — The Sera Labs, a wholly owned subsidiary of CURE Pharmaceutical Holdings (OTCQB: CURR) today announced its global expansion into...
by IR Team | Nov 16, 2021 | Press Releases
OXNARD, Calif. – CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company focused on pharmaceutical and health & wellness products, announced today that it received an issue...
by IR Team | Aug 17, 2021 | Press Releases
OXNARD, Calif. – CURE Pharmaceutical Holding Corp. (OTC: CURR), today announced results for the quarter ended June 30, 2021, including the following highlights: Revenue of $2.1 million reflected an increase of nearly 700% from a year ago Gross profit rose 676%...
by IR Team | Aug 4, 2021 | Press Releases
LOS ANGELES – Sera Labs, a subsidiary of CURE Pharmaceutical Holding Corp. (OTC: CURR), today announced that all six facial products of the Seratopical Revolution skincare line will be available for purchase at CVS in the Fall of 2021. CVS is one of the leading...
by IR Team | Jun 15, 2021 | Press Releases
OXNARD, Calif. – CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness markets, announced today that its Chief Business Officer...
by IR Team | Jun 10, 2021 | Press Releases
OXNARD, Calif. – CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has signed a partnership agreement with Biopharmaceutical Research Company, (BRC), an active Drug...